PMCF Study Fortilink-TC Ti
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is setup to be able to gather information on the safety and performance of the Fortilink-TC Ti cage of Paradigm Spine GmbH, up to one year after the surgery. The device is intended to be used in intervertebral fusion surgery. Around 50 participants will participate in this study in 2 hospitals. The Fortilink-TC Ti cage is meant to be placed in the lower back, to treat degenerative disc disease with up to grade I spondylolisthesis. The study will involve data gathering based on routine care. The study will only entail collection of data (medical history prior to the surgery, data from the surgery and data in the follow up after one year). Fortilink-TC Ti cages are not new, but have been on the market since 2020. The clinical study is performed to actively gather data on the use of this product in the intended group of patients, to monitor its safety and performance. The treatment and follow-up provided in this study does not differ from the standard of care; meaning that participants in the study will receive the same treatment and follow the same follow-up visits and assessments as patients undergoing the same procedure outside of the study.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Chęć dobrowolnego uczestnictwa i podpisanie zgody
- •Dorosłe osoby (szkielet w pełni ukształtowany)
- •Co najmniej 6 miesięcy leczenia bez operacji
- •Rozpoznanie zmian zwyrodnieniowych dysku w dolnej części kręgosłupa na 1-2 poziomach, potwierdzone badaniami
✗ Disqualifies
- •Aktywne infekcje w organizmie lub w miejscu zabiegu
- •Alergia na materiały implantu
- •Poważne osłabienie kości (osteoporoza)
- •Nowotwory pierwotne lub przerzuty w kręgosłup
- •Poważne otyłość lub inne choroby zwyrodnieniowe mogące negatywnie wpłynąć na implant
- •Niezdolność do wykonywania ćwiczeń i opieki porehabilitacyjnej
- •Złamania, silne zniekształcenia lub niestabilność w obszarze zabiegu
- •Ciąża
Simplified criteria — AI translation
Trial details
- Last updated (source)
- September 22, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (2)
Hospital Vithas de la Milagrosa
Madrid, Spain
Hospital Universitario Vithas Madrid Aravaca
Moncloa-Aravaca, Spain
Trial contact
Tess Jimenez - van Dam, MSc
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/23/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.